Bioequivalence Study of Carbidopa/Levodopa/Entacapone Combination vs. Carbidopa/Levodopa Combination Plus Entacapone in Healthy Volunteers

• Status: Completed
• Trial end date: 1969-12-31

Summary

The purpose of this study is to assess the safety and bioequivalence of a single oral dose of carbidopa+levodopa+entacapone combination versus a single oral dose of carbidopa+levodopa combination plus a single oral dose of entacapone under fed conditions in healthy volunteers.

• Phase: Phase 1

Details

• Lead Sponsor: Novartis
• Treatments: Carbidopa; Carbidopa, levodopa drug combination; Entacapone; Levodopa